References

Aiyagari V, Cross DT 3rd, Deibert E, Dacey RG Jr, Diringer MN.
Safety of hemodynamic augmentation in patients treated with Guglielmi detachable coils after acute aneurysmal subarachnoid hemorrhage.
Stroke. 2001 Sep;32(9):1994-7.

Barker FG 2nd, Ogilvy CS.
Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis.
J Neurosurg. 1996 Mar;84(3):405-14.

Brilstra EH, Rinkel GJ, Algra A, van Gijn J.
Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage.
Neurology. 2000 Dec 12;55(11):1656-60.

Bulsara KR, McGirt MJ, Liao L, Villavicencio AT, Borel C, Alexander MJ, Friedman AH.
Use of the peak troponin value to differentiate myocardial infarction from reversible neurogenic left ventricular dysfunction associated with aneurysmal subarachnoid hemorrhage.
J Neurosurg. 2003 Mar;98(3):524-8.

Dalbasti T, Karabiyikoglu M, Ozdamar N, Oktar N, Cagli S.
Efficacy of controlled-release papaverine pellets in preventing symptomatic cerebral vasospasm.
J Neurosurg. 2001 Jul;95(1):44-50.

Deibert E, Barzilai B, Braverman AC, Edwards DF, Aiyagari V, Dacey R, Diringer M.
Clinical significance of elevated troponin I levels in patients with nontraumatic subarachnoid hemorrhage.
J Neurosurg. 2003 Apr;98(4):741-6.

Deibert E, Aiyagari V, Diringer MN.
Reversible left ventricular dysfunction associated with raised troponin I after subarachnoid haemorrhage does not preclude successful heart transplantation.
Heart. 2000 Aug;84(2):205-7.

Diringer MN, Wu KC, Verbalis JG, Hanley DF.
Hypervolemic therapy prevents volume contraction but not hyponatremia following subarachnoid hemorrhage.
Ann Neurol. 1992 May;31(5):543-50.

Grubb RL Jr, Raichle ME, Eichling JO, Gado MH.
Effects of subarachnoid hemorrhage on cerebral blood volume, blood flow, and oxygen utilization in humans.
J Neurosurg. 1977 Apr;46(4):446-53.

Hasan D, Tanghe HL.
Distribution of cisternal blood in patients with acute hydrocephalus after subarachnoid hemorrhage.
Ann Neurol. 1992 Apr;31(4):374-8.

Hasan D, Lindsay KW, Wijdicks EF, Murray GD, Brouwers PJ, Bakker WH, van Gijn J, Vermeulen M.
Effect of fludrocortisone acetate in patients with subarachnoid hemorrhage.
Stroke. 1989 Sep;20(9):1156-61.

Hillman J, Fridriksson S, Nilsson O, Yu Z, Saveland H, Jakobsson KE.
Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study.
J Neurosurg. 2002 Oct;97(4):771-8.

Kasuya H, Onda H, Sasahara A, Takeshita M, Hori T
Application of nicardipine prolonged-release implants: analysis of 97 consecutive patients with acute subarachnoid hemorrhage.
Neurosurgery. 2005 May;56(5):895-902; discussion 895-902.


Kasuya H, Onda H, Takeshita M, Okada Y, Hori T.
Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans.
Stroke. 2002 Apr;33(4):1011-5.

Kawamoto S, Tsutsumi K, Yoshikawa G, Shinozaki MH, Yako K, Nagata K, Ueki K.
Effectiveness of the head-shaking method combined with cisternal irrigation with urokinase in preventing cerebral vasospasm after subarachnoid hemorrhage.
J Neurosurg. 2004 Feb;100(2):236-43.

Klimo P Jr, Kestle JR, MacDonald JD, Schmidt RH.
Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage.
J Neurosurg. 2004 Feb;100(2):215-24.

Kwak R, Niizuma H, Ohi T, Suzuki J.
Angiographic study of cerebral vasospasm following rupture of intracranial aneurysms: Part I. Time of the appearance.
Surg Neurol. 1979 Apr;11(4):257-62.

Lennihan L, Mayer SA, Fink ME, Beckford A, Paik MC, Zhang H, Wu YC, Klebanoff LM, Raps EC, Solomon RA.
Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage : a randomized controlled trial.
Stroke. 2000 Feb;31(2):383-91.

Lynch JR, Wang H, McGirt MJ, et al.
Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial.
Stroke. 2005 Sep;36(9):2024-6. Epub 2005 Jul 28.

Manno EM, Gress DR, Schwamm LH, Diringer MN, Ogilvy CS.
Effects of induced hypertension on transcranial Doppler ultrasound velocities in patients after subarachnoid hemorrhage.
Stroke. 1998 Feb;29(2):422-8.

Miller JA, Dacey RG Jr, Diringer MN.
Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage.
Stroke. 1995 Dec;26(12):2260-6.

Molyneux AJ, Kerr RS, Yu LM, et al.
International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion.
Lancet. 2005 Sep 3-9;366(9488):809-17.

Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, Holman R; International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group.
International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial.
Lancet. 2002 Oct 26;360(9342):1267-74.

Mori T, Katayama Y, Kawamata T, Hirayama T.
Improved efficiency of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage.
J Neurosurg. 1999 Dec;91(6):947-52.

Muizelaar JP, Zwienenberg M, Rudisill NA, Hecht ST.
The prophylactic use of transluminal balloon angioplasty in patients with Fisher Grade 3 subarachnoid hemorrhage: a pilot study.
J Neurosurg. 1999 Jul;91(1):51-8.

Qureshi AI, Sung GY, Razumovsky AY, Lane K, Straw RN, Ulatowski JA.
Early identification of patients at risk for symptomatic vasospasm after aneurysmal subarachnoid hemorrhage.
Crit Care Med. 2000 Apr;28(4):984-90.

Rajshekhar V, Harbaugh RE.
Results of routine ventriculostomy with external ventricular drainage for acute hydrocephalus following subarachnoid haemorrhage.
Acta Neurochir (Wien). 1992;115(1-2):8-14.

Roos YB, Rinkel GJ, Vermeulen M, Algra A, van Gijn J.
Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.
Cochrane Database Syst Rev. 2003;(2):CD001245.

Sheehan JP, Polin RS, Sheehan JM, Baskaya MK, Kassell NF.
Factors associated with hydrocephalus after aneurysmal subarachnoid hemorrhage.
Neurosurgery. 1999 Nov;45(5):1120-7; discussion 1127-8.

Smith MJ, Le Roux PD, Elliott JP, Winn HR.
Blood transfusion and increased risk for vasospasm and poor outcome after subarachnoid hemorrhage.
J Neurosurg. 2004 Jul;101(1):1-7.

Solomon RA, Post KD, McMurtry JG 3rd.
Depression of circulating blood volume in patients after subarachnoid hemorrhage: implications for the management of symptomatic vasospasm.
Neurosurgery. 1984 Sep;15(3):354-61.

Suarez JI, Shannon L, Zaidat OO, Suri MF, Singh G, Lynch G, Selman WR.
Effect of human albumin administration on clinical outcome and hospital cost in patients with subarachnoid hemorrhage.
J Neurosurg. 2004 Apr;100(4):585-90.

Suarez JI, Qureshi AI, Yahia AB, Parekh PD, Tamargo RJ, Williams MA, Ulatowski JA, Hanley DF, Razumovsky AY.
Symptomatic vasospasm diagnosis after subarachnoid hemorrhage: evaluation of transcranial Doppler ultrasound and cerebral angiography as related to compromised vascular distribution.
Crit Care Med. 2002 Jun;30(6):1348-55.

Treggiari MM, Walder B, Suter PM, Romand JA.
Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage.
J Neurosurg. 2003 May;98(5):978-84.

Tung P, Kopelnik A, Banki N, Ong K, Ko N, Lawton MT, Gress D, Drew B, Foster E, Parmley W, Zaroff J.
Predictors of neurocardiogenic injury after subarachnoid hemorrhage.
Stroke. 2004 Feb;35(2):548-51.

van den Bergh WM, Algra A, van Kooten F, et al. MASH Study Group.
Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial.
Stroke. 2005 May;36(5):1011-5. Epub 2005 Mar 24.

van den Bergh WM, Albrecht KW, Berkelbach van der Sprenkel JW, Rinkel GJ.
Magnesium therapy after aneurysmal subarachnoid haemorrhage a dose-finding study for long term treatment.
Acta Neurochir (Wien). 2003 Mar;145(3):195-9; discussion 199.

Vespa PM, Nuwer MR, Juhasz C, Alexander M, Nenov V, Martin N, Becker DP.
Early detection of vasospasm after acute subarachnoid hemorrhage using continuous EEG ICU monitoring.
Electroencephalogr Clin Neurophysiol. 1997 Dec;103(6):607-15.

Veyna RS, Seyfried D, Burke DG, Zimmerman C, Mlynarek M, Nichols V, Marrocco A, Thomas AJ, Mitsias PD, Malik GM.
Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage.
J Neurosurg. 2002 Mar;96(3):510-4.

Wijdicks EF, Vermeulen M, Hijdra A, van Gijn J.
Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysms: is fluid restriction harmful?
Ann Neurol. 1985 Feb;17(2):137-40.

Wurm G, Tomancok B, Nussbaumer K, Adelwohrer C, Holl K.
Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo.
Clin Neurol Neurosurg. 2004 Mar;106(2):97-103.